140 related articles for article (PubMed ID: 173654)
21. Susceptibility of varicella-zoster virus to thymidine analogues.
Machida H
Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
Holliday J; Williams MV
Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
O'Neill FJ; Goldberg RJ; Rapp F
J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
[No Abstract] [Full Text] [Related]
26. Synthesis and antiviral activity of the carbocyclic analogues of 5-ethyl-2'-deoxyuridine and of 5-ethynyl-2'-deoxyuridine.
Shealy YF; O'Dell CA; Arnett G; Shannon WM
J Med Chem; 1986 Jan; 29(1):79-84. PubMed ID: 3001308
[TBL] [Abstract][Full Text] [Related]
27. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
28. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
30. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
32. Levamisole and bovine immunity: in vitro and in vivo effects on immune responses to herpesvirus immunization.
Babiuk LA; Misra V
Can J Microbiol; 1981 Dec; 27(12):1312-9. PubMed ID: 6174193
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 5-[1-(2-halo(or nitro)ethoxy-2-iodoethyl)]-2'-deoxyuridines as inhibitors of herpes simplex virus.
Rai D; Saffran H; Kumar R
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):41-5. PubMed ID: 12751819
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1.
Carter JJ; Weinberg AD; Pollard A; Reeves R; Magnuson JA; Magnuson NS
J Virol; 1989 Apr; 63(4):1525-30. PubMed ID: 2538643
[TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of wild type and drug resistant mutant strains of bovine herpesvirus-1 (BHV-1) in the natural host.
Gilliam SE; Thackray AM; Brown GA; Field HJ
Arch Virol; 1993; 128(1-2):43-54. PubMed ID: 8380324
[TBL] [Abstract][Full Text] [Related]
36. Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils.
Rouse BT; Babiuk LA; Henson PM
J Infect Dis; 1980 Feb; 141(2):223-32. PubMed ID: 6154112
[TBL] [Abstract][Full Text] [Related]
37. Enhanced survival of ultraviolet-irradiated herpes simplex virus in cells exposed to antiviral agents.
Schnipper LE; Lewin AA; Crumpacker CS
Mutat Res; 1983 Feb; 116(2):65-72. PubMed ID: 6298618
[TBL] [Abstract][Full Text] [Related]
38. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
[TBL] [Abstract][Full Text] [Related]
39. A rapid antiviral drug test by enzyme-linked immunoassay.
Landini MP; Baldassarri B
Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087
[TBL] [Abstract][Full Text] [Related]
40. Attempts to standardize the screening for antiviral drugs by in vitro tests.
Schwöbel W; Streissle G; Kiefer G
Chemotherapy; 1979; 25(5):268-78. PubMed ID: 225134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
